Pathobiology of Hodgkin Lymphoma
Open Access
- 22 December 2010
- journal article
- review article
- Published by Hindawi Limited in Advances in Hematology
- Vol. 2011, 1-18
- https://doi.org/10.1155/2011/920898
Abstract
Despite its well-known histological and clinical features, Hodgkin's lymphoma (HL) has recently been the object of intense research activity, leading to a better understanding of its phenotype, molecular characteristics, histogenesis, and possible mechanisms of lymphomagenesis. There is complete consensus on the B-cell derivation of the tumor in most cases, and on the relevance of Epstein-Barr virus infection and defective cytokinesis in at least a proportion of patients. The REAL/WHO classification recognizes a basic distinction between lymphocyte predominance HL (LP-HL) and classic HL (cHL), reflecting the differences in clinical presentation and behavior, morphology, phenotype, and molecular features. cHL has been classified into four subtypes: lymphocyte rich, nodular sclerosing, with mixed cellularity, and lymphocyte depleted. The borders between cHL and anaplastic large-cell lymphoma have become sharper, whereas those between LP-HL and T-cell-rich B-cell lymphoma remain ill defined. Treatments adjusted to the pathobiological characteristics of the tumor in at-risk patients have been proposed and are on the way to being applied.Keywords
This publication has 142 references indexed in Scilit:
- Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphomaBlood, 2010
- The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escapeThe Journal of Pathology, 2010
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's LymphomaThe New England Journal of Medicine, 2010
- Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008Annals of Oncology, 2009
- Circulating clonotypic B cells in classic Hodgkin lymphomaBlood, 2009
- TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphomaThe Journal of Experimental Medicine, 2009
- Follicular Helper T Cells: Lineage and LocationImmunity, 2009
- Role of Chemotherapy in Hodgkin’s LymphomaThe Cancer Journal, 2009
- Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysisThe Journal of Experimental Medicine, 2008
- Chromosomal Abnormalities in Patients With Hodgkin's Disease: Evidence for Frequent Involvement of the 14q Chromosomal Region but Infrequent bcl-2 Gene Rearrangement in Reed-Sternberg CellsJNCI Journal of the National Cancer Institute, 1992